Guangzhou Fuda Biotechnology Co., Ltd.

Fuda Group operates 4 certified plants (3 China, 1 Indonesia) with 96 patents, offering OEM/ODM solutions for skincare, cosmetics, and disinfectants. Compliant with GMPC, ISO 22716, and QS standards, we deliver scalable, high-quality production for global markets.

500K+ daily capacity with fast customization.

100,000-class cleanrooms + EU/US equipment (HPLC, AA spectrometers).

Licenses: Cosmetics & Disinfectants.

R&D partnerships with Peking University, CAS, and 29+ institutes.

Key tech: Anti-aging delivery (nano-hyaluronic acid), plant extract stabilization (Ganoderma polysaccharides), advanced disinfection formulas.

Proven results: 85%+ skincare repurchase rate, ECOCERT/FDA approvals, 30+ markets served.

21-step QA with full traceability.

48-hour prototypes + 15-day mass production.

Clinically validated safety/efficacy.

✅ Science-led: 2 Chinese Academy Academicians + 16 experts.
✅ Global compliance: EU, ASEAN, North America.
✅ 96 patents (e.g., ectoin encapsulation).
✅ 40% faster time-to-market.

10+ anti-aging skincare lines (clinically proven).

High-performance disinfectants (international standards).

Full-cycle support: R&D, testing, logistics.

A Chronological History of Fuda Group

2002

Fuda Group is founded in Hong Kong, marking the beginning of its journey in the cosmetics and biotechnology industries.

2004

Construction begins on the first production base: the Baiyun District Cosmetics Factory in Guangzhou, China.

2005

The Guangzhou Baiyun District Cosmetics Factory is completed and officially begins operations.

2007

Launch of the second production base: Shandong Fuda Biotechnology Co., Ltd., expanding the group’s footprint into northern China.

2008

Establishes a joint laboratory with the South China Botanical Garden of the Chinese Academy of Sciences (led by researcher Qiu Shengxiang), focusing on plant extraction technologies.

2009

The Shandong Fuda Biotechnology production base is completed and begins operations, strengthening supply chain capabilities for northern markets.

2010

Partners with the Beijing Aging Research Center to establish the Fuda Bioengineering Research Institute, targeting health solutions for aging populations.

2015

Breaks ground on the third production base: Guangzhou Fuda Biotechnology Co., Ltd., reinforcing its presence in the Guangdong manufacturing hub.

2017

The Guangzhou Fuda Biotechnology facility is completed and becomes fully operational.

2020

Signs a strategic agreement with South China Agricultural University to co-develop advanced skincare formulations.

2021

            Expands global R&D collaborations:

•             Forms a joint lab with the U.S.-based Leslie Laboratory for biotech innovation.
•             Partners with the UK’s Anderson Laboratory to pioneer new cosmetic ingredients.
•             Wins the Gold Award at the China Beauty Expo for its Lingzhi (Reishi Mushroom) product line.

2022

Receives the National Scientific Innovation Award for its breakthrough "small-molecule encapsulation technology," a milestone in proprietary R&D.

2023

Annual sales exceed RMB 5 billion, reflecting rapid market growth and brand recognition.

2024

Announces a major investment to build its first overseas production base in Indonesia, targeting Southeast Asian markets.

2025

The Indonesia factory commences operations, marking Fuda’s official entry into global manufacturing.

2026 & Beyond

Plans to deepen innovation in biotechnology and wellness sectors, advance sustainable practices, and expand international partnerships to realize its vision of becoming a globally influential Chinese brand.

Legacy & Vision
From a Hong Kong startup to a multinational enterprise, Fuda Group’s 20-year journey exemplifies relentless innovation, strategic expansion, and a commitment to merging scientific excellence with consumer needs. With a foundation in cutting-edge research and global ambition, Fuda continues to redefine the future of beauty and health worldwide.

Fuda Group delivers full-cycle OEM/ODM services tailored to global brands in skincare, cosmetics, and disinfectants, combining cutting-edge R&D, scalable production, and rigorous quality assurance.

• Custom Formulation Development

  • Leverage 96 patented technologies (e.g., nano-hyaluronic acid delivery, plant extract stabilization) to create unique, market-ready products.

  • Collaborate with our R&D team (partnered with Peking University, CAS, and 29+ institutes) for science-backed innovations.

• Agile Production & Scalability

  • 500,000+ units/day capacity across 4 GMPC/ISO 22716-certified plants.

  • 48-hour prototyping and 15-day mass production cycles for fast market entry.

  • Support small-batch customization and large-volume orders.

• Quality & Compliance Assurance

  • 21-step quality control process with full batch traceability.

  • Clinically validated efficacy and safety testing.

  • Compliance expertise for EU, ASEAN, and North American markets.

• End-to-End Support

  • Regulatory guidance: Navigate certifications (e.g., FDA, ECOCERT) and regional standards.

  • Logistics optimization: Streamlined global distribution from China/Indonesia hubs.

  • Market insights: Data-driven recommendations for formulation trends and consumer demands.

✅ Science-driven innovation: Backed by 2 Chinese Academy Academicians and 16 industry experts.
✅ Global-ready infrastructure: 100,000-class cleanrooms, precision EU/US equipment (HPLC, AA spectrometers).
✅ Proven success: 85%+ repurchase rate for skincare lines, 30+ countries served.

With 13,000+ dedicated professionals and 132,000 direct sales specialists, Fuda Group operates as a vertically integrated powerhouse, blending scientific innovation, precision manufacturing, and omnichannel market dominance to deliver end-to-end solutions for global partners.

R&D & Scientific Brain Trust (45 Experts)

Led by 2 Chinese Academy Academicians, supported by 11 PhDs/MScs and 16 life science authorities.

Focus: Plant bioactive extraction (e.g., Ganoderma polysaccharides), anti-aging delivery systems (nano-hyaluronic acid), disinfection tech.

Output: 96 patents commercialized, 20+ exclusive formulas/year.

Quality Command (25 Specialists)

Military-grade precision: 21-step QC protocol, 100% batch traceability, 0.1% defect tolerance.

Tech backbone: HPLC, AA spectrometers, ISO 22716/GMPC-certified labs.

Operational Engine (1,126 Professionals)

1:117 support efficiency – 1 logistics expert sustains 117 frontline sales agents.

Manages 4 global plants (3 China, 1 Indonesia), enabling 500K+ units/day output.

Commercial Force (36 Strategists + 132K Field Agents)

36 elite planners: Data-driven market insights for 30+ countries.

132K feet-on-street: Direct retail penetration, achieving 15-day global product launches.

From nano-level formulations to continental-scale distribution, our human capital transforms science into shelf presence.